{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:30:13Z","timestamp":1759026613722},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,18]]},"DOI":"10.18632\/oncotarget.15552","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"25837-25847","source":"Crossref","is-referenced-by-count":12,"title":["Tumorigenesis promotes Mdm4-S overexpression"],"prefix":"10.18632","volume":"8","author":[{"given":"Vinod","family":"Pant","sequence":"first","affiliation":[{"name":"Department of Genetics, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie A.","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Genetics, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Aryal","sequence":"additional","affiliation":[{"name":"Department of Genetics, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunbin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Genetics, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Quintas-Cardama","sequence":"additional","affiliation":[{"name":"Department of Leukemia, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[{"name":"Department of Genetics, M.D. Anderson Cancer Center, Houston, Texas, 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/j.1460-2075.1996.tb00919.x","article-title":"MDMX: a novel p53-binding protein with some functional properties of MDM2","volume":"15","author":"Jochemsen","year":"1996","journal-title":"EMBO J"},{"key":"2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng714","article-title":"Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53","volume":"29","author":"Lozano","year":"2001","journal-title":"Nat Genet"},{"key":"3","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/MCB.22.15.5527-5538.2002","article-title":"Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development","volume":"22","author":"Marine","year":"2002","journal-title":"Mol Cell Biol"},{"key":"4","first-page":"3221","article-title":"mdmx is a negative regulator of p53 activity in vivo","volume":"62","author":"Zhang","year":"2002","journal-title":"Cancer Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1101\/gad.16722111","article-title":"Validation of MdmX as a therapeutic target for reactivating p53 in tumors","volume":"25","author":"Evan","year":"2011","journal-title":"Genes Dev"},{"key":"6","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1073\/pnas.1102241108","article-title":"Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability","volume":"108","author":"Lozano","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.1102309108","article-title":"The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo","volume":"108","author":"Yuan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.11023","article-title":"Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target","volume":"104","author":"Reifenberger","year":"2003","journal-title":"International journal of cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1128\/MCB.24.13.5835-5843.2004","article-title":"Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity","volume":"24","author":"Jochemsen","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10","first-page":"1839","article-title":"Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53","volume":"61","author":"Jochemsen","year":"2001","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ijc.21206","article-title":"Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis","volume":"117","author":"Hauptmann","year":"2005","journal-title":"International journal of cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature05194","article-title":"Inactivation of the p53 pathway in retinoblastoma","volume":"444","author":"Rodriguez-Galindo","year":"2006","journal-title":"Nature"},{"key":"13","article-title":"Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End","author":"Lozano","year":"2016","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138920209787581280","article-title":"MDM4 (MDMX) and its Transcript Variants","volume":"10","author":"Moretti","year":"2009","journal-title":"Current genomics"},{"key":"15","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1074\/jbc.274.12.8299","article-title":"A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity","volume":"274","author":"Hall","year":"1999","journal-title":"J Biol Chem"},{"key":"16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jcb.10535","article-title":"Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells","volume":"89","author":"Hall","year":"2003","journal-title":"Journal of cellular biochemistry"},{"key":"17","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-12-0215","article-title":"Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer","volume":"72","author":"Bond","year":"2012","journal-title":"Cancer Res"},{"key":"18","first-page":"68","article-title":"Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth","volume":"126","author":"Tan","year":"2016","journal-title":"J Clin Invest"},{"key":"19","first-page":"876173","article-title":"Functions of MDMX in the modulation of the p53-response","volume":"2011","author":"Jochemsen","year":"2011","journal-title":"Journal of biomedicine & biotechnology"},{"key":"20","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/cas.12008","article-title":"S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia","volume":"103","author":"Xu","year":"2012","journal-title":"Cancer science"},{"key":"21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.CAN-14-2637","article-title":"Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer","volume":"75","author":"Bond","year":"2015","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"17814","DOI":"10.1073\/pnas.1317398110","article-title":"MDMX contains an autoinhibitory sequence element","volume":"110","author":"Fersht","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1158\/0008-5472.CAN-10-1457","article-title":"Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4","volume":"70","author":"Lozano","year":"2010","journal-title":"Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/onc.2014.230","article-title":"Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity","volume":"34","author":"Toledo","year":"2015","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.189.1.123","article-title":"Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes","volume":"189","author":"Alt","year":"1999","journal-title":"The Journal of experimental medicine"},{"key":"26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.leu.2402363","article-title":"Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities","volume":"16","author":"Vilpo","year":"2002","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/MCB.26.1.192-198.2006","article-title":"Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4","volume":"26","author":"Lozano","year":"2006","journal-title":"Mol Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Croce","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1101\/gad.219899.113","article-title":"Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery","volume":"27","author":"Guccione","year":"2013","journal-title":"Genes Dev"},{"key":"30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1470-2045(07)70104-3","article-title":"Alternative splicing: an emerging topic in molecular and clinical oncology","volume":"8","author":"Montuenga","year":"2007","journal-title":"The Lancet Oncology"},{"key":"31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nsmb.1608","article-title":"Cancer-associated regulation of alternative splicing","volume":"16","author":"Rancourt","year":"2009","journal-title":"Nature structural & molecular biology"},{"key":"32","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2013-02-427641","article-title":"SF3B1 mutations in chronic lymphocytic leukemia","volume":"121","author":"Wu","year":"2013","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:13:11Z","timestamp":1596723191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":32,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4,18]]}},"alternative-id":["15552","28460439"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15552","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]}}}